Despite the limited number of participants, SARS-CoV-2-specific CD4+GRB+ values were found to be distinct among MIS-C, COVID-19, and healthy controls and were specifically lower in acute MIS-C compared to COVID-19 but higher compared to healthy controls. This evidence concerns the gene CD4 and COVID-19.